Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zhong Ji Longevity Science Group Limited ( (HK:0767) ) has shared an announcement.
Zhong Ji Longevity Science Group Limited reported a slight 2.7% decline in revenue to HK$161.8 million for 2025, while gross profit more than halved due to higher costs. Despite this pressure on margins, the group’s net loss narrowed by about 52.9% to HK$16.4 million as selling and administrative expenses fell sharply and other income improved.
The company’s net assets increased 6.2% to HK$425.0 million, indicating a stronger balance sheet even as it remained loss-making. The board decided not to declare a final dividend, underscoring a conservative capital stance as the group focuses on stabilising profitability and strengthening its financial position for stakeholders.
The most recent analyst rating on (HK:0767) stock is a Sell with a HK$0.47 price target. To see the full list of analyst forecasts on Zhong Ji Longevity Science Group Limited stock, see the HK:0767 Stock Forecast page.
More about Zhong Ji Longevity Science Group Limited
Zhong Ji Longevity Science Group Limited is a Bermuda-incorporated company listed in Hong Kong that operates across businesses related to longevity science and associated services. The group focuses on generating revenue from diversified operations in its sector, positioning itself within Hong Kong’s listed mid-cap space with an emphasis on asset-backed growth and capital preservation for shareholders.
Average Trading Volume: 354,128
Technical Sentiment Signal: Buy
Current Market Cap: HK$318.3M
Learn more about 0767 stock on TipRanks’ Stock Analysis page.